PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,515,506 | -24.6% | 1,017,958 | -4.4% | 0.23% | -22.1% |
| Q2 2023 | $13,952,776 | -48.1% | 1,064,285 | -55.7% | 0.30% | -50.3% |
| Q1 2023 | $26,862,231 | -56.7% | 2,402,704 | -35.4% | 0.60% | -51.5% |
| Q3 2022 | $61,990,000 | +21.5% | 3,720,901 | +7.4% | 1.23% | +17.3% |
| Q2 2022 | $51,018,000 | -44.4% | 3,465,901 | -6.2% | 1.05% | -48.7% |
| Q1 2022 | $91,681,000 | +20.8% | 3,695,341 | +56.1% | 2.05% | +28.8% |
| Q4 2021 | $75,905,000 | +3.9% | 2,366,867 | +16.6% | 1.59% | +11.7% |
| Q3 2021 | $73,035,000 | -8.1% | 2,029,887 | +12.7% | 1.42% | +1.0% |
| Q2 2021 | $79,455,000 | +85.4% | 1,800,887 | +92.2% | 1.41% | +56.6% |
| Q1 2021 | $42,860,000 | +34.0% | 937,032 | +102.2% | 0.90% | +42.6% |
| Q4 2020 | $31,992,000 | – | 463,511 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |